VOLUME 4; ISSUE 3 2025 Editor Prof Shingai Mutambirwa - Urologist MBChB, MMed (Urology) Medunsa Head of Urology - Sefako Makgatho Health Sciences University Chairman - The South African Urological Association Academic committee Chairman - Medical and Scientic Advisory Board of The Prostate Cancer Foundation Editorial Board Dr. Sheynaz Bassa - Clinical and Radiation Oncologist MBChB (Univ of Natal), FC Rad (Onc) SA Head of Department: Radiation Oncology Steve Biko Academic Hospital and The University of Pretoria Dr Jireh Serfontein - Medical Sexologist MBChB (Pret.), Dip HIV Management, MMed Sexual Health (Univ. Sydney) Clinical head: My Sexual Health Pretoria Editorial and Publishing Ofce Maria Philippou Randburg 2194 Enquiries 082 3355 444 Publisher Maria Philippou Andrew Oberholzer Disclaimer All rights reserved. No editorial matter published in Urology, Urooncology and Sexology Update may be reproduced in any form or language without written permission from the publishers. While every effort is made to ensure accurate reproduction, the Prostate Cancer Foundation, the authors, publishers and their employees or agents shall not be responsible or in any way liable for any errors, omissions or inaccuracies in the publication whether arising from negligence or for any consequences arising there from. The inclusion or exclusion of any product does not mean that the Prostate Cancer Foundation, the publisher or the editorial board advocates or rejects its use either generally or in any particular eld or elds. This publication is intended for registered healthcare professionals only. If you received this publication or a link to this publication in error, please do not directly or indirectly use, print, copy, forward, or disclose any part of this publication. Please delete the copy or link to the publication and notify the publisher. UROLOGY, URO-ONCOLOGY AND SEXOLOGY UPDATE CONTENTS 1 UROLOGY, URO-ONCOLOGY AND SEXOLOGY UPDATE Supported by: Adjustment for imbalances in baseline characteristics in the MAGNITUDE phase 3 study conrms the clinical benet of niraparib in combination with abiraterone acetate plus prednisone in patients with metastatic prostate cancer. An interview with Dr. Karlheinz Jehle, president of the South African Urological Association Advanced delivery of leuprorelin acetate for the treatment of prostatic cancer Suit UP Saturday at the SA Congress of Oncology in Sandton on 13 September Thank you to our 2025 supporters! Empowering South African Men with Prostate Cancer: Join the Free PC-PEP Phase 4 Trial Suit Up Saturday at ESAU Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update Canvas of Courage An oncologist's depictions of the emotional triad of fear, overwhelming uncertainty, and unrelenting hope faced by patients diagnosed with cancer and mental illness. 2 4 6 11 12 13 17 18 21
RkJQdWJsaXNoZXIy NTIyOTQ=